Log in
OTCMKTS:MYDP

Dougherty's Pharmacy Stock Forecast, Price & News

$0.0090
0.00 (0.00 %)
(As of 09/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.01
Now: $0.01
$0.01
50-Day Range
$0.01
MA: $0.01
$0.01
52-Week Range
$0.01
Now: $0.01
$0.07
VolumeN/A
Average Volume40,315 shs
Market Capitalization$207,882.00
P/E RatioN/A
Dividend YieldN/A
Beta4.28
Dougherty's Pharmacy, Inc., an investment firm, focuses on acquiring, managing, and growing community based pharmacies in the Southwest Region of the United States. Its flagship store is Dougherty's Pharmacy, a turn-key multi-service pharmacy located in Dallas, Texas. The company was formerly known as Ascendant Solutions, Inc. and changed its name to Dougherty's Pharmacy, Inc. in May 2017. Dougherty's Pharmacy, Inc. was founded in 1998 and is based in Dallas, Texas.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.46 out of 5 stars


Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:MYDP
CUSIPN/A
Phone972-250-0945

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$36.05 million
Book Value($0.08) per share

Profitability

Miscellaneous

Employees75
Market Cap$207,882.00
Next Earnings DateN/A
OptionableNot Optionable
$0.0090
0.00 (0.00 %)
(As of 09/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MYDP News and Ratings via Email

Sign-up to receive the latest news and ratings for MYDP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Dougherty's Pharmacy (OTCMKTS:MYDP) Frequently Asked Questions

How has Dougherty's Pharmacy's stock been impacted by Coronavirus?

Dougherty's Pharmacy's stock was trading at $0.01 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MYDP stock has decreased by 10.0% and is now trading at $0.0090.
View which stocks have been most impacted by COVID-19
.

How were Dougherty's Pharmacy's earnings last quarter?

Dougherty's Pharmacy Inc (OTCMKTS:MYDP) issued its quarterly earnings results on Tuesday, August, 14th. The company reported ($0.02) earnings per share for the quarter. The company earned $9.17 million during the quarter.
View Dougherty's Pharmacy's earnings history
.

Who are some of Dougherty's Pharmacy's key competitors?

What other stocks do shareholders of Dougherty's Pharmacy own?

Who are Dougherty's Pharmacy's key executives?

Dougherty's Pharmacy's management team includes the following people:
  • Mr. James C. Leslie CPA, CPA, Chairman & Sec. (Age 64)
  • Mr. Stewart I. Edington, Pres, CEO, Interim CFO & Director (Age 71)
  • Ms. Katherine Burrow, Managing Director of Bus. Devel.
  • Ms. Susan K. Olson, Sec.
  • Ms. Robin Bruce, Controller

What is Dougherty's Pharmacy's stock symbol?

Dougherty's Pharmacy trades on the OTCMKTS under the ticker symbol "MYDP."

How do I buy shares of Dougherty's Pharmacy?

Shares of MYDP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Dougherty's Pharmacy's stock price today?

One share of MYDP stock can currently be purchased for approximately $0.01.

How big of a company is Dougherty's Pharmacy?

Dougherty's Pharmacy has a market capitalization of $207,882.00 and generates $36.05 million in revenue each year. Dougherty's Pharmacy employs 75 workers across the globe.

What is Dougherty's Pharmacy's official website?

The official website for Dougherty's Pharmacy is www.doughertys.com.

How can I contact Dougherty's Pharmacy?

Dougherty's Pharmacy's mailing address is 5924 ROYAL LANE SUITE 250, DALLAS TX, 75230. The company can be reached via phone at 972-250-0945 or via email at [email protected]

This page was last updated on 9/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.